[ad_1]
The California State Teachers Retirement System decreased its position in OPKO Health (NASDAQ: OPK) by 3.3% in the first quarter, according to its most recent Form 13F filed with the Securities & Exchange Commission The institutional investor held 535,389 shares of the biotech company after selling 18,085 shares during the quarter The California State Teachers Retirement System held 0.10% of OPKO Health for $ 1,697,000 at the end last quarter
Other major investors have also recently changed their holdings of the company: Castleview Partners LLC has acquired a new stake in OPKO Health in the first quarter of a value of about 103,000 $ First Trust Advisors LP acquired a new stake in OPKO Health in the fourth Xact Kapitalforvaltning AB bought a new position in OPKO Health shares during the 4th quarter valued at approximately $ 179,000. Stone Ridge Asset Management LLC has purchased a new position in OPKO Health shares during the 4th quarter valued at approximately $ 221,000. Finally, Meitav Dash Investments Ltd. bought a new position in shares of OPKO Health during the 4th quarter worth about $ 347,000. 23.83% of the shares are held by institutional investors.
Incidentally, CEO Phillip Md And Al Frost acquired 55,372 OPKO Health shares as part of a transaction that occurred on Wednesday, April 25th. The shares were purchased at an average cost of $ 2.99 per share, for a total transaction of $ 165,562.28. As a result of the purchase, the Chief Executive Officer now holds directly 3,068,951 shares of the Company, valued at approximately $ 9,176,163.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible via this hyperlink. In addition, Robert Scott Fishel acquired 12,500 shares of OPKO Health in a transaction on Wednesday, April 25th. The shares were purchased at an average price of $ 2.97 per share, for a total transaction of $ 37,125.00. The disclosure for this purchase can be found here. Insiders purchased 696,921 shares valued at $ 2,582,397 in the last 90 days. 42.74% of the stock is currently held by insiders of the company.
OPK has been the subject of several reports of research badysts. BidaskClub pbaded OPKO Health from a "strong sell" rating to a "sell" note in a research note on Thursday, April 19. ValuEngine pbaded OPKO Health from a "strong sale" rating to a "sell" note in a research note on Wednesday, May 2nd. Cantor Fitzgerald reiterated a "buy" note and set a target price of $ 20.00 on OPKO Health shares in a research note on Tuesday, May 8. Zacks Investment Research upgraded OPKO Health from a "sell" rating to a "hold" rating and set a target price of $ 4.75 for the company in a research note on Wednesday, May 9th. Finally, Barrington Research reiterated a "buy" note and set a target price of $ 7.00 on OPKO Health shares in a research note on Wednesday, May 9. Two financial badysts evaluated the stock with a sales note, two issued a reserve note, three issued a purchase note and one issued a strong buy note at the end of the year. ;action. The company currently has a consensual rating of "Hold" and a consensus target price of $ 10.21.
OPKO Health stock opened at $ 5.89 on Friday. The company has a market capitalization of $ 3.43 billion, a capitalization ratio of -20.31 and a beta of 1.71. The company has a debt ratio of 0.03, a ratio of 1.10 and a ratio of 0.94. OPKO Health has a 52-week low of $ 2.66 and a high of $ 524 in 52 weeks.
OPKO Health (NASDAQ: OPK) released its financial results for the last time on Tuesday, May 8th. The biotech company reported earnings per share of $ 0.08 for the quarter, up $ 0.05 from consensus estimates from Thomson Reuters ($ 0.13). The company achieved a turnover of $ 254.90 million during the quarter, compared with $ 236.90 million for badysts. OPKO Health had a negative return on equity of 8.76% and a negative net margin of 31.27%. Company revenues declined 4.3% from one year to the next. During the same period the previous year, the company posted earnings per share of $ 0.06. Analysts predict that OPKO Health will post earnings per share of -0.27 for the current year.
About OPKO Health
OPKO Health, Inc., a health care company, specializes in diagnostics and pharmaceuticals in the United States, Ireland, Chile , Spain, Israel and Mexico. The Company's Diagnostics segment operates Bio-Reference Laboratories, a clinical laboratory that provides laboratory testing services for the detection, diagnosis, evaluation, monitoring and treatment of diseases.
] Institutional Property by Quarter for OPKO Health (NASDAQ: OPK) "title =" Institutional Property Per Quarter for OPKO Health (NASDAQ: OPK) "/>
Get Help What's New in OPKO Health Daily – Enter your email address below to receive a concise daily summary of the latest news and badyst ratings for OPKO Health and related companies with the free daily newsletter from MarketBeat.com.
Source link
